Kezar Life Sciences Inc. (NASDAQ: KZR) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT KEZAR LIFE SCIENCES INC.

Kezar Life Sciences Inc. (NASDAQ: KZR)
Listen to this Section


$6.46
+0.2150 ( +1.49% ) 12.9K

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Market Data


Open $6.46
Previous Close $6.24
Volume 12.9K
Market Cap $46.40M
Day Range $6.14 - $6.46
52 Week Range $5.20 - $11.35
Shares Outstanding 7.30M
Change % +1.49%
Net Change ▲ 0.2150
Insider Ownership -0.03%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2018
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -5,251,688.00

Date Type Amount Purchased Purchaser
2024-07-26 Sale -6688.00 Schiller Mark C.
2024-06-21 Sale -50000.00 Wallace Courtney
2024-06-21 Sale -50000.00 Klearman Micki
2024-06-21 Sale -50000.00 Kauffman Michael
2024-06-21 Sale -50000.00 Garner Elizabeth
2024-06-21 Sale -50000.00 COOPER GRAHAM K
2024-06-21 Sale -50000.00 BERGER FRANKLIN M
2024-01-09 Sale -295000.00 Belsky Marc
2024-01-09 Sale -275000.00 Mordwinkin Nicholas Michael
2023-11-09 Sale -875000.00 Kirk Christopher J.

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
schedule Other 7 Jan 16, 2025
4 Insider transactions 1 Jan 13, 2025
4 Insider transactions 1 Jan 13, 2025
4 Insider transactions 1 Jan 13, 2025
8-k 8K-related 14 Jan 10, 2025
8-k 8K-related 12 Dec 03, 2024
8-k 8K-related 11 Nov 14, 2024
schedule Other 1 Nov 14, 2024
8-k 8K-related 12 Nov 12, 2024
10-q Quarterly Reports 77 Nov 12, 2024

Latest News


× Before browsing our site, please accept our cookies policy